This research demonstrates the anticancer and antibacterial potential of nickel oxide nanoparticles synthesized from licorice extract, highlighting its therapeutic importance.
In this study, nickel oxide nanoparticles (NiO-NPs) were synthesized using nickel nitrate hexahydrate and licorice leaves extract, which served as both a reducing agent and a capping agent. The optical, structural, and microscopic properties of the NiO-NPs were characterized using a range of techniques, including UV-visible spectroscopy, Fourier transform infrared spectroscopy, energydispersive X-ray analysis, field emission scanning electron microscopy, and atomic force microscopy. The bio-reducing potential of Licorice leaves was examined using gas chromatography-mass spectroscopy for phytochemical analysis of plant extract. Furthermore, cell cytotoxicity investigation was conducted on the Mg-63 cell line derived from osteosarcoma by the MTT method .The results showed that the viability of cancer cells was reduced with increasing NiO NPs concentration up to 28.78% for MG-63 Cells at the maximum concentration (500 μg/ml) in comparison with 80.79 % for HFF cell viability as control cells, while the antimicrobial experiments have demonstrated that NiO–NP action of two types of gram-positive bacteria and for two types of gram-negative bacteria. The results showed that NiO NPs had the highest antibacterial activity at high concentrations (1024 ug/ mL), forming the largest inhibition zone against Escherichia coli, Pseudomonas aeruginosa, Staphylococci aureus and Streptococcus with inhibition zones 18mm,18mm ,15mm and 22 mm respectively.
No takes yet. Share an insight, caveat, or question.
Mehrabian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: